Literature DB >> 4609599

High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms.

C D Buckner, R A Clift, A Fefer, D D Funk, H Glucksberg, P E Neiman, A Paulsen, R Storb, E D Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609599

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

Review 1.  High-dose chemotherapy and stem cell transplantation for advanced testicular cancer.

Authors:  Martin H Voss; Darren R Feldman; Robert J Motzer
Journal:  Expert Rev Anticancer Ther       Date:  2011-07       Impact factor: 4.512

Review 2.  Standard versus high-dose chemotherapy in mediastinal germ cell tumors: a narrative review.

Authors:  Emilio Francesco Giunta; Margaret Ottaviano; Alessandra Mosca; Giuseppe Luigi Banna; Pasquale Rescigno
Journal:  Mediastinum       Date:  2022-03-25

Review 3.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Cyclophosphamide cardiotoxicity.

Authors:  G von Bernuth; D Adam; R Hofstetter; D Lang; W Mohr; E Kohne; D Niethammer
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

5.  High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.

Authors:  M J Barnett; C M Coppin; N Murray; T J Nevill; D E Reece; H G Klingemann; J D Shepherd; S H Nantel; H J Sutherland; G L Phillips
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.